Advanced Prostate Cancer Consensus Conference (APCCC 2021)

Novartis 177Lu-PSMA-617 significantly improves overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer in Phase III VISION study

Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal NETTER-1 study with targeted radioligand therapy Lutathera

Congrès National Annuel du GTE 2021

ESMO (European Society for Medical Oncology) Congress

NANETS (North American Neuroendocrine Tumor Society) Symposium

34th Annual Congress of the European Association of Nuclear Medicine (EANM)

7èmes Journées Françaises de Médecine Nucléaire (JFMN)

American Society of Clinical Oncology (ASCO) Annual Meeting

Journées d’Onco-Urologie Médicale (JOUM)